Interleukin Genetics Reports Second Quarter 2009 Financi...(looking statements. ...)

              INTERLEUKIN GENETICS, INC. AND SUBSIDIARIES
                           FINANCIAL HIGHLIGHTS

    Balance Sheet Data:          30-Jun      31-Dec
                                   2009        2008
                                   ----        ----
                             (Unaudited)  (Audited)

    Cash and cash equivalents  $851,526  $4,952,481
    Total current assets      5,660,319   6,866,284
    Total assets             $7,634,065 $12,154,388

    Total current
     liabilities             $4,122,193  $3,666,961
    Total liabilities         9,122,193   7,671,961

    Total shareholders'
     (deficit) equity        (1,488,128)  4,482,427

    Total liabilities and
     shareholders' (deficit)
     equity                  $7,634,065 $12,154,388


    Statement of Operations
     Data (Unaudited):            Three Months Ended        Six Months Ended
                                       June 30,                  June 30,
                                   2009        2008        2009        2008
                                   ----        ----        ----        ----
    Revenue:
      Genetic testing service
       revenue                  $95,309     $90,993     $232,821    $192,745
      Contract research revenue 119,046     402,280      322,732     939,293
      Other                       8,638      28,346       14,904      31,453

        Total revenue from
         continuing operations  222,993     521,619      570,457   1,163,491

    Operating costs and
     expenses:
      Cost of genetic testing
       services                 301,875     208,457      606,847     443,241
      Research and development  874,192     708,855    1,755,748   1,522,226
      Selling, general and
       administrative         1,334,472   1,208,325    2,813,625   2,667,637
      Amortization of
       intangibles               28,863    
'/>"/>
SOURCE  Interleukin Genetics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 
Related biology technology :

1. Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
2. Interleukin Genetics to Present at the 2009 BIO Business Forum
3. Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
4. Interleukin Genetics Receives Notification of Failure to Meet Continued Listing Standard Section 1003(a)(iii)
5. Interleukin Genetics Appoints Todd Anthony Walker as Vice President, Marketing
6. Interleukin Genetics Reports Third Quarter 2008 Financial Results
7. Interleukin Genetics to Present New Findings on Osteoporosis at the 58th Annual Meeting of the American Society of Human Genetics
8. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
9. Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests
10. Interleukin Genetics Licenses its PST(R) Genetic Test to OralDNA Labs
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Second Quarter 2008 Business Results